Ignatia Bryophyllum (Uriel Pharmacy Inc.)


Welcome to the PulseAid listing for the Ignatia Bryophyllum drug offered from Uriel Pharmacy Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Uriel Pharmacy Inc.
NON-PROPRIETARY NAME: Ignatia Bryophyllum
SUBSTANCE NAME: KALANCHOE DAIGREMONTIANA LEAF; STRYCHNOS IGNATII SEED; SILVER; LACHESIS MUTA VENOM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00


Ignatia Bryophyllum HUMAN OTC DRUG Details:

Item DescriptionIgnatia Bryophyllum from Uriel Pharmacy Inc.
LABELER NAME: Uriel Pharmacy Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 4; 10; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 48951-5069_576e9282-5186-6536-e053-2a91aa0a6a4f
PRODUCT NDC: 48951-5069
APPLICATION NUMBER:

Other KALANCHOE DAIGREMONTIANA LEAF; STRYCHNOS IGNATII SEED; SILVER; LACHESIS MUTA VENOM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Uriel Pharmacy Inc.Ignatia Bryophyllum